SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-001142
Filing Date
2021-01-25
Accepted
2021-01-25 08:33:12
Documents
14
Period of Report
2021-01-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vcyt20210124_8k.htm   iXBRL 8-K 29424
2 EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS ex_222251.htm EX-3.1 135875
  Complete submission text file 0001437749-21-001142.txt   331556

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20210122.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcyt-20210122_def.xml EX-101.DEF 11972
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20210122_lab.xml EX-101.LAB 16010
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20210122_pre.xml EX-101.PRE 12181
7 EXTRACTED XBRL INSTANCE DOCUMENT vcyt20210124_8k_htm.xml XML 2664
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 21548079
SIC: 8071 Services-Medical Laboratories